Fri, January 29, 2021
Thu, January 28, 2021
Wed, January 27, 2021
Tue, January 26, 2021
Mon, January 25, 2021
Fri, January 22, 2021

Andrew Berens Maintained (AGIO) at Buy with Increased Target to $55 on, Jan 27th, 2021


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. ith-increased-target-to-55-on-jan-27th-2021.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Andrew Berens of SVB Leerink, Maintained "Agios Pharmaceuticals, Inc." (AGIO) at Buy with Increased Target from $51 to $55 on, Jan 27th, 2021.

Andrew has made no other calls on AGIO in the last 4 months.



There are 2 other peers that have a rating on AGIO. Out of the 2 peers that are also analyzing AGIO, 0 agree with Andrew's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Andrew


  • John Newman of "Canaccord Genuity" Maintained at Strong Buy with Decreased Target to $57 on, Monday, December 28th, 2020
  • Peter Lawson of "Barclays" Upgraded from Hold to Buy and Held Target at $46 on, Thursday, October 22nd, 2020

Publication Contributing Sources